PALSAR
LIVE

Serial Number

88607972

Owner

SEKISUI MEDICAL CO., LTD.

Attorney

Boris Umansky

Filing Date

Sep 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PALSAR Trademark

Serial Number: 88607972 • Registration: 7215616

PALSAR is a trademark filed by SEKISUI MEDICAL CO., LTD. on September 6, 2019. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

SEKISUI MEDICAL CO., LTD. (20 trademarks)

13-5, NIHOMBASHI 3-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

September 6, 2019

Registration Date

November 14, 2023

Published for Opposition

January 3, 2023

Goods & Services

Nucleic acid sequences as reagents for use in genetic research, other than for medical or veterinary purposes; nucleic acids for scientific purposes, chemical compositions and materials in the nature of chemicals for use in genotyping, all as chemicals for use in industry; reagents, enzymes, chemical compositions, chemical primers and chemical probes for use in the manufacture of pharmaceuticals; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; nucleic acid sequences known as probes for use in signal amplification for use in the manufacture of diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in signal amplification techniques for use in the pharmaceutical industry; nucleic acid sequences known as probes for use in detecting nucleic acids for raw material in the manufacture of pharmaceuticals; nucleic acid sequences known as probes for use in detecting mRNA directly without synthesizing cDNA for use as a raw material in the manufacture of diagnostic reagents; nucleic acid sequences known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use as a raw material in the manufacture of diagnostic reagents for scientific or research use; nucleic acid sequences known as probes for use in forming self-assembly honeycomb structure for use as an ingredient in pharmaceuticals; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment for use as an ingredient in diagnostic reagents; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for an ingredient in diagnostic reagents for scientific or medical research; nucleic acid sequences known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for as diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in quantifying using samples from blood, tissue and cell lysates for use in cell cultures other than for medical or veterinary use; nucleic acid sequences known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for diagnostic reagents and preparations, except for medical or veterinary use; nucleic acid sequences known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in self-assembly reactions for as reagents for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes to be used as signal amplifier for use in industry to detect nucleic acids; nucleic acid sequences known as probes for use in analyzing samples without using PCR for use in industry to detect mRNAs; biochemical reagents commonly known as probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembly formed by a short DNA probe pair for use in industry utilizing technology of DNA self-assembly reactions

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 12, 2023 DP1B
NOTICE OF ALLOWANCE CANCELLED
Aug 28, 2023 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 28, 2023 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 28, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2022 CRFA
ASSIGNED TO LIE
Oct 25, 2022 ALIE
ASSIGNED TO LIE
Sep 19, 2022 ALIE
ASSIGNED TO LIE
Sep 14, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 6, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 31, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 31, 2022 GNSL
SUSPENSION LETTER WRITTEN
Mar 31, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 10, 2022 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 13, 2021 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 10, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 10, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 10, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 4, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 4, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 4, 2021 CNSL
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2020 CNRT
DIVISIONAL PROCESSING COMPLETE
Jul 16, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 15, 2020 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2020 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2020 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 24, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 24, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 24, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 24, 2020 COAR
ASSIGNED TO LIE
Jun 16, 2020 ALIE
DIVISIONAL REQUEST RECEIVED
Jun 8, 2020 DRRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2020 TROA
TEAS REQUEST TO DIVIDE RECEIVED
Jun 8, 2020 ERTD
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2020 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2020 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 23, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2019 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Sep 11, 2019 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 11, 2019 PARI
NEW APPLICATION ENTERED
Sep 10, 2019 NWAP